Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)
NCT05963568
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
680
Enrollment
OTHER
Sponsor class
Conditions
Stroke
Medication Adherence
Interventions
DRUG:
Polycap
Sponsor
Northern California Institute of Research and Education